The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC).
 
David B. Page
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme; NanoString Technologies; Nektar; Syndax
Speakers' Bureau - Genentech/Roche
Research Funding - MedImmune (Inst); Merck
Expert Testimony - Philips Healthcare
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MedImmune
 
Isaac K Kim
No Relationships to Disclose
 
Katherine Sanchez
No Relationships to Disclose
 
Nicole Moxon
No Relationships to Disclose
 
Staci L. Mellinger
Travel, Accommodations, Expenses - Roche
 
Alison Katherine Conlin
Consulting or Advisory Role - Novartis; Pfizer
 
Anupama Kurup Acheson
No Relationships to Disclose
 
Kelly Shea Perlewitz
No Relationships to Disclose
 
Stacy K. Lewis
No Relationships to Disclose
 
Kathleen A. Kemmer
No Relationships to Disclose
 
Zahi Ibrahim Mitri
Consulting or Advisory Role - Novartis; Pfizer
 
Reva K Basho
Employment - Castlewood Treatment Center (I); DaVita (I)
Honoraria - InSightec; Navigant Consulting
Consulting or Advisory Role - HERON; Puma Biotechnology
 
Emily Riffle
No Relationships to Disclose
 
Jenny Ahn
No Relationships to Disclose
 
Joanna Pucilowska
No Relationships to Disclose
 
Maritza Martel
Consulting or Advisory Role - Bristol-Myers Squibb (I)
 
Walter John Urba
Leadership - Leidos Biomedical Research
Stock and Other Ownership Interests - Pfizer
Honoraria - Bristol-Myers Squibb; Celldex; MedImmune; Newlink Genetics; OncoSec
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Celldex; eTheRNA; GreenPeptide; MedImmune (Inst); Newlink Genetics; OncoSec
Research Funding - Bristol-Myers Squibb (Inst); Galectin Therapeutics (Inst); MedImmune (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Galectin Therapeutics (Inst); MedImmune (Inst)
Travel, Accommodations, Expenses - AgonOx; Bristol-Myers Squibb; eTheRNA; Leidos Biomedical Research; MedImmune
 
Heather L. McArthur
Consulting or Advisory Role - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Peregrine Pharmaceuticals; Roche; Spectrum Pharmaceuticals; Syndax; TapImmune Inc.
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); ZIOPHARM Oncology (Inst)
Travel, Accommodations, Expenses - Amgen; Calithera Biosciences; Lilly; Merck; OBI Pharma; Roche; Spectrum Pharmaceuticals
Other Relationship - Lilly; OBI Pharma